351 related articles for article (PubMed ID: 33524788)
1. Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways.
Dou Y; Huang R; Li Q; Liu Y; Li Y; Chen H; Ai G; Xie J; Zeng H; Chen J; Luo C; Su Z
Biomed Pharmacother; 2021 May; 137():111312. PubMed ID: 33524788
[TBL] [Abstract][Full Text] [Related]
2. Comparison of anti-inflammatory effects of berberine, and its natural oxidative and reduced derivatives from Rhizoma Coptidis in vitro and in vivo.
Li CL; Tan LH; Wang YF; Luo CD; Chen HB; Lu Q; Li YC; Yang XB; Chen JN; Liu YH; Xie JH; Su ZR
Phytomedicine; 2019 Jan; 52():272-283. PubMed ID: 30599908
[TBL] [Abstract][Full Text] [Related]
3. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z
Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats.
Li QP; Dou YX; Huang ZW; Chen HB; Li YC; Chen JN; Liu YH; Huang XQ; Zeng HF; Yang XB; Su ZR; Xie JH
Phytomedicine; 2021 May; 85():153550. PubMed ID: 33831691
[TBL] [Abstract][Full Text] [Related]
5. Intestines-erythrocytes-mediated bio-disposition deciphers the hypolipidemic effect of berberine from Rhizoma Coptidis: A neglected insight.
Huang Z; Li M; Qin Z; Ma X; Huang R; Liu Y; Xie J; Zeng H; Zhan R; Su Z
J Ethnopharmacol; 2023 Oct; 314():116600. PubMed ID: 37196811
[TBL] [Abstract][Full Text] [Related]
6. Oxyberberine ameliorates TNBS-induced colitis in rats through suppressing inflammation and oxidative stress via Keap1/Nrf2/NF-κB signaling pathways.
Li C; Liu M; Deng L; Luo D; Ma R; Lu Q
Phytomedicine; 2023 Jul; 116():154899. PubMed ID: 37247589
[TBL] [Abstract][Full Text] [Related]
7. Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats.
Chen K; Li G; Geng F; Zhang Z; Li J; Yang M; Dong L; Gao F
Apoptosis; 2014 Jun; 19(6):946-57. PubMed ID: 24664781
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo hypoglycemia effect of oxyberberine, a novel HO-1 agonist: A renewed evidence linking HO-1 to diabetes mellitus.
Dou Y; Ai G; Huang R; Huang Z; Li Y; Liu Y; Xie J; Chen J; Su Z
Phytomedicine; 2022 Jul; 101():154135. PubMed ID: 35509133
[TBL] [Abstract][Full Text] [Related]
9. Anti-Inflammatory Activation of Phellodendri Chinensis Cortex is Mediated by Berberine Erythrocytes Self-Assembly Targeted Delivery System.
Li M; Qin Z; Yu Q; Huang Z; Cheng J; Zhong L; Liu Y; Xie J; Li Y; Chen J; Zhan R; Su Z
Drug Des Devel Ther; 2022; 16():4365-4383. PubMed ID: 36583113
[TBL] [Abstract][Full Text] [Related]
10. A comparative investigation of the interaction and pharmacokinetics of hemoglobin with berberine and its oxymetabolite.
Chen HB; Luo CD; Ai GX; Wang YF; Li CL; Tan LH; Lee SM; Cheung AK; Su ZR; Wu XL; Xie JH; Zeng HF
J Pharm Biomed Anal; 2021 May; 199():114032. PubMed ID: 33774454
[TBL] [Abstract][Full Text] [Related]
11. Protective Effects of Oxyberberine in 5-Fluorouracil-Induced Intestinal Mucositis in the Mice Model.
Huang R; Ai G; Zhong L; Mai L; Chen JN; Liu Y; Li Y; Huang X; Su Z; Zhan JY
Evid Based Complement Alternat Med; 2022; 2022():1238358. PubMed ID: 35677366
[TBL] [Abstract][Full Text] [Related]
12. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.
Xie X; Chang X; Chen L; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
Mol Cell Endocrinol; 2013 Dec; 381(1-2):56-65. PubMed ID: 23896433
[TBL] [Abstract][Full Text] [Related]
13. Berberine promotes peri-implant osteogenesis in diabetic rats by ROS-mediated IRS-1 pathway.
Shao J; Liu S; Zheng X; Chen J; Li L; Zhu Z
Biofactors; 2021 Jan; 47(1):80-92. PubMed ID: 33233028
[TBL] [Abstract][Full Text] [Related]
14. Berberine activates Nrf2 nuclear translocation and inhibits apoptosis induced by high glucose in renal tubular epithelial cells through a phosphatidylinositol 3-kinase/Akt-dependent mechanism.
Zhang X; Liang D; Lian X; Jiang Y; He H; Liang W; Zhao Y; Chi ZH
Apoptosis; 2016 Jun; 21(6):721-36. PubMed ID: 26979714
[TBL] [Abstract][Full Text] [Related]
15. Berberine, a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth.
Hsu YY; Tseng YT; Lo YC
Toxicol Appl Pharmacol; 2013 Nov; 272(3):787-96. PubMed ID: 23954465
[TBL] [Abstract][Full Text] [Related]
16. Hypoglycemic Mechanism of the Berberine Organic Acid Salt under the Synergistic Effect of Intestinal Flora and Oxidative Stress.
Cui HX; Hu YN; Li JW; Yuan K
Oxid Med Cell Longev; 2018; 2018():8930374. PubMed ID: 30662584
[TBL] [Abstract][Full Text] [Related]
17. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.
Yao Y; Chen H; Yan L; Wang W; Wang D
Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246
[TBL] [Abstract][Full Text] [Related]
18. Antidiabetic effects of pterostilbene through PI3K/Akt signal pathway in high fat diet and STZ-induced diabetic rats.
Sun H; Liu X; Long SR; Teng Wang ; Ge H; Wang Y; Yu S; Xue Y; Zhang Y; Li X; Li W
Eur J Pharmacol; 2019 Sep; 859():172526. PubMed ID: 31283935
[TBL] [Abstract][Full Text] [Related]
19. Berberine activates Nrf2 nuclear translocation and protects against oxidative damage via a phosphatidylinositol 3-kinase/Akt-dependent mechanism in NSC34 motor neuron-like cells.
Hsu YY; Chen CS; Wu SN; Jong YJ; Lo YC
Eur J Pharm Sci; 2012 Aug; 46(5):415-25. PubMed ID: 22469516
[TBL] [Abstract][Full Text] [Related]
20. The Hypoglycemic Effect of Berberine and Berberrubine Involves Modulation of Intestinal Farnesoid X Receptor Signaling Pathway and Inhibition of Hepatic Gluconeogenesis.
Sun R; Kong B; Yang N; Cao B; Feng D; Yu X; Ge C; Feng S; Fei F; Huang J; Lu Z; Xie Y; Yang CS; Guo GL; Wang G; Aa J
Drug Metab Dispos; 2021 Mar; 49(3):276-286. PubMed ID: 33376148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
